Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin (SAIL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2012 by University of Manitoba
Sponsor:
Collaborator:
Novo Nordisk A/S
Information provided by (Responsible Party):
Dr. Vincent Woo, University of Manitoba
ClinicalTrials.gov Identifier:
NCT01628445
First received: June 21, 2012
Last updated: August 14, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given